GlobeNewswire

ConnectWise Launches Unite, Its Cloud Monitoring, Management and Billing Solution

Dela

IT Nation Europe keynote also reveals plans for an advanced security dashboard and growing the company's international footprint

LONDON, April 19, 2018 (GLOBE NEWSWIRE) -- ConnectWise CEO Arnie Bellini told an audience of more than 350 at the company's annual IT Nation Europe conference in London that ConnectWise Unite is now available to technology teams across the globe. Unite is a cloud management solution that gives technology teams the ability to manage, monitor and bill a broad range of cloud-based solutions through a single pane of glass and in their own currency.

"Technology teams typically take advantage of a broad range of cloud solutions to meet their customers' unique needs. What we've done with ConnectWise Unite is give our partners the ability to access these disparate solutions from a single pane of glass and greatly simplify the complexity that comes from dealing with the growing number of solutions they use," Bellini said.

He explained that connecting the ecosystem seamlessly within Unite enables teams to more effectively and profitably deliver managed services to their clients, all while driving recurring revenues.

"We believe in a completely open ecosystem that offers technology teams choices in how they meet the unique needs of their customers, so we understand that teams need a tool to help them efficiently manage all their solutions. ConnectWise Unite does just this and returns to our partners the time they need to focus on providing their customers with great support and growing their businesses," Bellini said.

ConnectWise Unite integrations today include Amazon Web Services (AWS), Cisco Meraki, Cisco Spark, Cisco Stealthwatch Cloud, Cisco Umbrella, Microsoft Azure and Microsoft Office 365. Additional vendor solutions will be added based on partner needs and feedback.    

Advanced Security Dashboard

Bellini told audience members the company is preparing to launch the ConnectWise Advanced Security Dashboard, giving technology teams the ability to monitor a client's multiple security solutions from a single pane of glass. The Dashboard will incorporate endpoint security, network security, edge and application security, and testing and reporting.

He said ConnectWise has teamed once again with Cisco and will launch the Advanced Security Dashboard with many of Cisco's security solutions, including Cisco Advanced Malware Protection (AMP) for Endpoints, Cisco Advanced Security Appliances (ASA) and Cisco Next Generation Firewall (NGFW).

The ConnectWise Advanced Security Dashboard will be piloted in May for a select group of Cisco partners. Its launch is slated for September.  

International Growth

Bellini also touted the success ConnectWise is experiencing outside of the United States and told IT Nation Europe attendees about plans to beef up the company's presence in Australia and increase its presence in South Africa.

"Today, ConnectWise solutions are used by more 22,000 businesses in over 70 countries, and international revenue grew by 23 percent last year," he said. "The reception we've received outside the United States has been phenomenal, and we're doubling down on our commitment to ensuring technology teams across the globe have access to our award-winning solutions, stellar support team and amazing community."

Bellini reported that ConnectWise has experienced more than a 37 percent increase in the number of partners in Australia during the last two years, and that Australia and New Zealand all together accounted for almost 7.4 percent of ConnectWise's revenue in 2017. To ensure it can continue to meet the needs of its partners in this part of the world, ConnectWise opened a new office in Sydney, Australia, this month and is increasing the number of colleagues dedicated to the Australia and New Zealand market. The new office overlooks Darling Harbour and allows partners to receive on-site product training, education and face-to-face time with their account managers.

ConnectWise also is expanding its outreach to South Africa, where it already has a several dozen partners. The company is looking to double that number over the next year and has hired a team to support this effort, according to Gregg Lalle, Vice President of International Sales and Strategy for ConnectWise.

"Over the past several years, we stepped up our commitment to Europe and APAC, and we're proud of our impact there. When ConnectWise is successful, our partners have been successful, and that's what we strive for each and every day," said Lalle. "ConnectWise has wanted to expand into South Africa for some time now and we're thrilled to begin this push. We're applying the learnings from our previous international efforts to ensure we can increase the efficiency and productivity of companies based in South Africa as quickly as possible."

IT Nation Europe 2018, the largest European conference of its kind, provides three days of collaboration, networking and educational content for technology team members. To learn more about IT Nation Europe, visit the ConnectWise IT Nation Europe website

Follow ConnectWise  
LinkedIn
ConnectWise Blog
Twitter  
Facebook
YouTube

About ConnectWise
ConnectWise is a software company that connects technology teams to the solutions, services and resources necessary for success. Our award-winning business management platform automates the full lifecycle of technology service delivery, from sales and service to project tracking and back-office functions, for more than 22,000 in more than 70 countries. We believe in an open ecosystem, the power of choice and providing a single pane of glass view. With more than 35 years of experience, ConnectWise software solutions deliver the support companies want at each step of their business journey. For more information, visit www.ConnectWise.com.

Press Contacts
Elizabeth Bassler
EBassler@ConnectWise.com
Diane Rose for ConnectWise
diane@dkrcomms.com

A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/930e4424-8f14-4595-908c-8613e31e572c




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ConnectWise via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum